|Previous Section||Index||Home Page|
Lady Hermon: To ask the Secretary of State for Foreign and Commonwealth Affairs what discussions he has had with (a) Commonwealth and (b) African Union counterparts regarding the human rights situation in Zimbabwe. 
My noble Friend the Parliamentary Under-Secretary of State for Foreign and Commonwealth Affairs (Lord Triesman of Tottenham) and my right hon. Friend the Secretary of State for International Development (Hilary Benn) attended the recent African Union Summit in Libya where they discussed Zimbabwe with African and other leaders, including the African Union Chairperson Alpha Konare and United Nations Secretary General Kofi Annan. We continue to make clear our view that African leaders should engage with the Government of Zimbabwe to seek an end to the ongoing human rights abuses.
We remain in regular dialogue with our Commonwealth partners. Many have joined us in condemning the appalling human rights violations of the Government of Zimbabwe, most recently statements by the Governments of Australia and New Zealand condemning the human rights situation and calling for further international action.
13 Jul 2005 : Column 1124W
Mr. Byrne [holding answer 30 June 2005]: The location and suitability of the site were agreed between the host national health service trust and Alliance Medical Ltd. (AML). AML is contractually obliged to comply with existing health and safety legislation and is responsible for patient and staff safety inside the mobile unit.
Mr. Byrne [holding answer 4 July 2005]: The Department does not hold the information requested about staff working for Alliance Medical Ltd. who are expected not to recruit staff who have been employed by the national health service in the preceding six-month period.
Rates of pay for most non-medical staff working in the national health service are based on the new pay and reward system, Agenda for Change. Details of Agenda for Change, including current pay bands and rates, are available at:
Sandra Gidley: To ask the Secretary of State for Health what monitoring her Department (a) has undertaken and (b) plans to undertake of the prescription of (i) olanzapine, (ii) risperidone and (iii) other anti-psychotics for people with dementia. 
Mr. Lansley: To ask the Secretary of State for Health what funding has been provided for research into(a) ulcerative colitis and (b) Crohn's disease from the Department's research and development programme. 
The Department's national research programme spend on projects related to inflammatory bowel disease in the period from 1994 to 2004 was £503,000. This figure includes part of the cost of a project on combined measles, mumps and rubella vaccine safety in relation to juvenile Crohn's disease.
13 Jul 2005 : Column 1125W
Over 75 per cent. of the Department's total expenditure on health research is devolved to and managed by national health service organisations. Details of completed and ongoing projects, including a number concerned with ulcerative colitis and with Crohn's disease, can be found on the national research register at www.dh.gov.uk/research.
Mr. Byrne: It is for primary care trusts to commission appropriate local services according to local need in order to improve care for people with long-term conditions, as set out in the NHS Improvement Plan.
Lynne Jones: To ask the Secretary of State for Health how many complaints have been made to the Advertising Standards Authority (ASA) about breast milk substitute advertising in the UK in the last three years; and whether the ASA has issued a ruling in response to all complaints. 
Caroline Flint: I am not in a position to answer this question as issues relating to advertising complaints are the responsibility of the Advertising Standards Authority (ASA), which is an independent body. Any questions relating to the number of complaints made about breast milk substitute advertising should be referred directly to the head of complaints at the ASA.
Mr. Byrne: There are no special arrangements available for small charities to meet annual fees. However, in setting the fees in 200203, the cost of registering and inspecting different types and sizes of service providers, was taken into account.
The Government cannot exempt charities from paying annual fees as this would be unfair to other care providers. All providers benefit from the assurance that regulation gives, including the voluntary sector.
13 Jul 2005 : Column 1126W
Mr. Amess: To ask the Secretary of State for Health what estimate she has made of the number of children who died as a result of breathing in their mother's cigarette smoke in the last year for which figures are available. 
Mr. Byrne: Information about the level of social service provision is not held centrally. It is for the local social services to decide how resources should be allocated between services, taking account of local circumstances and priorities.
Jane Kennedy: The table shows the expenditure on major information campaigns and advertising commissioned by the Department's communications directorate for the past five years200001 to 200405. The figures include the costs of campaign-related publishing, television radio, poster, newspaper and magazine advertising.
|Financial year||£ million|
Mr. Lansley: To ask the Secretary of State for Health how many (a) completed consultant episodes and (b) deaths relating to digestive conditions and diseases there have been in each year since 1997, broken down by gender. 
|Diagnosis grouping of digestive conditions and diseases||Female||Male||Not known|
|K00-K14 Diseases of oral cavity, salivary glands and jaws||96,604||72,764||1,924|
|K20-K31 Diseases of oesophagus, stomach and duodenum||129,042||145,394||1,118|
|K35-K38 Diseases of appendix||16,608||19,531||206|
|K50-K52 Non infective enteritis and colitis||51,055||42,480||577|
|K55-K63 Other diseases of intestines||105,452||87,267||1,056|
|K65-K67 Diseases of peritoneum||3,890||2,173||38|
|K70-K77 Diseases of liver||7,810||10,785||63|
|K80-K87 Disorders of gall bladder, biliary tract and pancreas||62,437||34,410||583|
|K90-K93 Other diseases of the digestive system.||21,757||23,945||276|
|K00-K14 Diseases of oral cavity, salivary glands and jaws||104,361||80,455||76|
|K20-K31 Diseases of oesophagus, stomach and duodenum||138,348||155,011||92|
|K35-K38 Diseases of appendix||16,169||19,656||13|
|K50-K52 Non infective enteritis and colitis||53,980||44,120||25|
|K55-K63 Other diseases of intestines||114,389||95,205||48|
|K65-K67 Diseases of peritoneum||4,075||2,232||1|
|K70-K77 Diseases of liver||8,217||11,009||24|
|K80-K87 Disorders of gall bladder, biliary tract and pancreas||64,068||35,467||22|
|K90-K93 Other diseases of the digestive system.||23,476||25,215||10|
|K00-K14 Diseases of oral cavity, salivary glands and jaws||100,946||78,878||189|
|K20-K31 Diseases of oesophagus, stomach and duodenum||140,408||155,131||266|
|K35-K38 Diseases of appendix||16,247||20,001||60|
|K50-K52 No infective enteritis and colitis||57,202||46,396||132|
|K55-K63 Other diseases of intestines||122,087||100,538||242|
|K65-K67 Diseases of peritoneum||3,922||2,253||9|
|K70-K77 Diseases of liver||8,370||11,550||20|
|K80-K87 Disorders of gall bladder, biliary tract and pancreas||67,094||36,141||111|
|K90-K93 Other diseases of the digestive system.||24,712||26,441||47|
|K00-K14 Diseases of oral cavity, salivary glands and jaws||96,013||77,028||181|
|K20-K31 Diseases of oesophagus, stomach and duodenum||137,892||151,473||173|
|K35-K38 Diseases of appendix||16,799||20,628||34|
|K50-K52 No infective enteritis and colitis||58,473||46,975||273|
|K55-K63 Other diseases of intestines||125,202||103,438||279|
|K65-K67 Diseases of peritoneum||4,166||2,384||9|
|K70-K77 Diseases of liver||8,689||11,825||31|
|K80-K87 Disorders of gall bladder, biliary tract and pancreas||71,811||38,170||42|
|K90-K93 Other diseases of the digestive system.||24,750||26,782||36|
|K00-K14 Diseases of oral cavity, salivary glands and jaws||93,393||76,893||190|
|K20-K31 Diseases of oesophagus, stomach and duodenum||131,380||141,036||303|
|K35-K38 Diseases of appendix||15,754||19,617||32|
|K50-K52 No infective enteritis and colitis||59,254||47,700||201|
|K55-K63 Other diseases of intestines||119,458||100,099||263|
|K65-K67 Diseases of peritoneum||4,087||2,395||10|
|K70-K77 Diseases of liver||8,840||12,339||12|
|K80-K87 Disorders of gall bladder, biliary tract and pancreas||73,258||38,616||100|
|K90-K93 Other diseases of the digestive system.||24,822||26,833||39|
|K00-K14 Diseases of oral cavity, salivary glands and jaws||93,698||76,489||46|
|K20-K31 Diseases of oesophagus, stomach and duodenum||129,021||138,630||22|
|K35-K38 Diseases of appendix||15,799||19,851||5|
|K50-K52 No infective enteritis and colitis||63,130||50,681||9|
|K55-K63 Other diseases of intestines||120,665||102,297||17|
|K65-K67 Diseases of peritoneum||4,043||2,430||1|
|K70-K77 Diseases of liver||9,050||12,806||5|
|K80-K87 Disorders of gall bladder, biliary tract and pancreas||76,394||39,785||2|
|K90-K93 Other diseases of the digestive system.||24,726||26,984||6|
|K00-K14 Diseases of oral cavity, salivary glands and jaws||94,478||77,583||48|
|K20-K31 Diseases of oesophagus, stomach and duodenum||126,202||133,943||30|
|K35-K38 Diseases of appendix||16,467||19,995||2|
|K50-K52 No infective enteritis and colitis||65,417||51,607||12|
|K55-K63 Other diseases of intestines||124,667||105,118||19|
|K65-K67 Diseases of peritoneum||4,016||2,301|||
|K700-K77 Diseases of liver||9,304||13,808||2|
|K80-K87 Disorders of gall bladder, biliary tract and pancreas||80,244||42,072||8|
|K90-K93 Other diseases of the digestive system.||25,354||28,334||2|
Mr. Lansley: To ask the Secretary of State for Health what funding has been provided for research into digestive diseases and conditions from (a) the Medical Research Council and (b) the Department's research and development programme. 
Jane Kennedy: The main agency through which the Government supports medical and clinical research is the Medical Research Council (MRC). The MRC is an independent body funded by the Department of Trade and Industry via the Office of Science and Technology.
The Department funds research to support policy and to provide the evidence needed to underpin quality improvement and service development in the national health service. The Department's national research programme spend on projects related to digestive diseases and conditions in 200304 was £1.3 million.
Over 75 per cent. of the Department's total expenditure on health research is devolved to and managed by NHS organisations. Details of completed and on-going projects supported by this funding can be found on the national research register at www.dh.gov.uk/research.
1 Areas of research counted for this purpose include: inflammatory bowel diseases, Crohn's disease, ulcerative colitis, cholangitis, irritable bowel syndrome, intestinal diseases, gastrointestinal diseases, peptic ulcers, abdominal pain, pancreatitis, gastroenteritis, gastric and intestinal mucosa, dysentery, colonic diseases.
|Next Section||Index||Home Page|